From the Journals

In patients with untreated AIDS, monkeypox can be life-threatening


 

FROM THE MMWR

Fewer cases, some severe

As of Nov. 7, the CDC has confirmed 28,709 monkeypox cases. These have trended downward since August. Most people with recent diagnoses are men who are gay, bisexual, same gender loving, or who have sex with men, and most are Black, according to Brooks.

Dr. Brooks urges clinicians to report suspected monkeypox cases – especially severe ones – to their health departments.

“We don’t have a good bead on exactly how many severe cases there are in the States because of complexities in our surveillance systems,” Dr. Brooks said.

For patients with suspected or confirmed monkeypox, Brooks recommends testing for sexually transmitted infections, including HIV if status is unknown. Patients with HIV should receive prompt ART. For those at risk for severe disease, the authors recommend early treatment for suspected monkeypox, even before results are back. Some patients may benefit from tecovirimat courses lasting beyond 14 days, plus additional antivirals (cidofovir or brincidofovir) and/or VIGIV.

“With severe cases, clinicians may want to consider the value of more than one drug to attack the virus at different stages of its replication cycle,” Dr. Brooks said.

Inequities matter

The authors called on providers to engage communities burdened by HIV and to ensure access to not only monkeypox vaccination, diagnosis, and treatment but also sustained HIV care.

Dr. Silvera added that providers need to tailor care plans to patients’ social determinants of health. For example, he explained, inpatient care for monkeypox could be appropriate for some patients facing homelessness and food insecurity – even if they are able to take tecovirimat orally.

He recommends tapping others’ expertise: “Our social work colleagues are well versed in this.”

“I don’t think these clinicians failed these patients. ... I think everyone made all the right choices medically,” Dr. Silvera added. “I think that the system failed these patients – and we as clinicians are part of those systems. So we also have the power to change those systems. And I think we just need to start opening our eyes to that and [start] to work together towards that goal to take better care of our patients.”

Dr. Brooks reported no relevant financial disclosures.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Injectable HIV prevention better than pills in two trials
MDedge Internal Medicine
Dolutegravir in pregnant patients with HIV showed more viral suppression at delivery vs. other treatments
MDedge Internal Medicine
Texas district court allows employers to deny HIV PrEP coverage
MDedge Internal Medicine
Hep C, HIV coinfection tied to higher MI risk with age
MDedge Internal Medicine
A switch to B/F/TAF keeps HIV suppressed, even with M184V/I mutation
MDedge Internal Medicine
FDA approves HIV-1 treatment ibalizumab for 30-second IV push
MDedge Internal Medicine
Gardasil 9 HPV vaccine advised for MSM living with HIV
MDedge Internal Medicine
Increased HIV infection linked to pandemic-related access to PrEP
MDedge Internal Medicine
Monkeypox presentations, prevention strategies shifting
MDedge Internal Medicine
Life expectancy 6.3 years shorter for Black MSM with HIV
MDedge Internal Medicine